Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Thomas Stephen Basil | Dir | S Sale | — | $13.67 | $1.4M | filing |
| Jun 30, 2026 | Brennan Aoife | Pres, CEO | S SaleOE | — | $13.17 | $407K | filing |
CLIMB BIO INC (CLYM) insider trading activity (SEC Form 4). Over the trailing 90 days, CLYM insiders filed 0 purchases totalling $0 and 2 sales totalling $1.8M — net SELLING of $1.8M. Most recent filing: Sep 17, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.